MAPT and Alzheimer disease: Scientists have found that micro RNA (miRNA) imbalance in AD patients and models is related to amyloid precursor protein (APP) expression, production of Aβ, deposition of pathological tau protein, inflammatory response, and damage to the cytoskeleton, leading to synaptic disorder (Wang et al., 2019; Jash et al., 2020).